References
Archived Content
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please "contact us" to request a format other than those available.
1. Public Health Agency of Canada. Life and Breath: Respiratory Disease in Canada. Ottawa: Public Health Agency of Canada, 2007. Available at http://www.phac-aspc.ca
2. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Canadian Respiratory Journal 2007; 14(Suppl. B): 5B-32B.
3. Buist A, McBurnie M, Vollmer W, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50.
4. Hodder R. COPD a social disease: Inappropriateness and pharmaco-economics. The situation in North America: The view from Canada. Multidisciplinary Respiratory Medicine 2010; 5: 119-21.
5. Chapman K, Bourbeau J, Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respiratory Medicine 2003; 97: 23-31.
6. Canadian Lung Association. Chronic Obstructive Pulmonary Disease (COPD): A National Report Card. Ottawa: Canadian Lung Association, 2005. Available at http://www.lung.ca
7. Patel BD, Coxson HO, Pillai SG, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2008; 178(5): 500-5.
8. Snider GL. Nosology for our day: its application to chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2003; 167: 678-83.
9. Girod CE, Schwarz MI. Other large-airway diseases that limit airflow. In: Voelkel NF, MacNee W, eds. Chronic Obstructive Lung Diseases. Hamilton, Ontario: B.C. Decker, 2002.
10. Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. European Respiratory Journal 2004; 23: 932-46.
11. Statistics Canada. Canadian Community Health Survey—Annual Component. Available at http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3226&Item_Id=118913
12. Hill K, Goldstein RS, Guyatt GH, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. Canadian Medical Association Journal 2010; 182: 673-8.
13. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. European Respiratory Journal 2007; 30: 232.
14. Mannino DM, Gognon RC, Petty T, et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Archives of Internal Medicine 2000; 160: 1683-9.
15. Tremblay M, Langlois R, Bryan S, et al. Canadian Health Measures Survey Pre-test: Design, methods, results. Health Reports 2007; 18(Suppl.): 21-30.
16. Tremblay M,Wolfson M, Connor Gorber S. Canadian Health Measures Survey: Background, rationale and overview Health Reports 2007; 18(Suppl.):7-20.
17. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. European Respiratory Journal 2005; 26: 153-61.
18. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. European Respiratory Journal 2005; 26: 319-38.
19. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. American Journal of Respiratory and Critical Care Medicine 1999; 159: 179-87.
20. Committee on Research into Chronic Bronchitis. Questionnaire in Respiratory Symptoms: Instructions for Its Use. London: Medical Research Council, 1966.
21. Global Initiative for Chronic Obstructive Lung Disease. Updated 2009 Executive Summary. Accessed August 29, 2011 at http://www.goldcopd.com
22. Hill K, Hodder R, Blouin M, et al. Identifying adults at risk of COPD who need confirmatory spirometry in primary care: Do symptom-based questions help? Canadian Family Physician 2011; 57: e51-7.
23. Anatomical Therapeutic Chemical (ATC) Classification System Codes. Accessed April, 2010 at http://www.whocc.no/atc_index
24. Rao JNK, Wu CFJ, Yue K. Some recent work on resampling methods for complex surveys. Survey Methodology (Statistics Canada, Catalogue 12-001) 1992; 18: 209-17.
25. Rust KF, Rao JNK. Variance estimation for complex surveys using replication techniques. Statistical Methods in Medical Research 1996; 5: 281-310.
26. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. Journal of Clinical Epidemiology 2000; 53: 755-61.
27. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. American Journal of Respiratory and Critical Care Medicine 1996; 153: 1530-5.
28. Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45: 579-85.
29. Lokke A, Ulrik CS, Dahl R, et al. Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice. COPD 2012; 9(5): 458-65.
30. Camp PG, Chaudhry M, Platt H, et al. The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia. Canadian Respiratory Journal 2008;15(8): 417-22.
31. Johannessen A, Omenaas ER, Bakke PS, et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-7.
32. Schermer TRJ, Smeele IJM, Thoonen BPA, et al. Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. European Respiratory Journal 2008; 32: 945-52.
33. Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-51.
34. Miller MR, Pederson OF, Pellegrino R, et al. Debating the definition of airflow obstruction: time to move on? European Respiratory Journal 2009; 34: 527-8.
35. Pellegrino R, Brusasco V, Viegi G, et al. Definition of COPD: based on evidence or opinion? European Respiratory Journal 2008; 31: 681-2.
36. Vollmer WM, Gíslason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. European Respiratory Journal 2009; 34: 588-97.
37. Shirtcliffe P, Weatherall M, Marsh S, et al. COPD prevalence in a random population survey: a matter of definition. European Respiratory Journal 2007; 30: 232.
38. Mannino DM. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow-up study. Thorax 2003; 58: 388-93.
39. Sterk PJ. Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. European Respiratory Journal 2004; 23: 497-8.
40. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. European Respiratory Journal 2005; 26: 948-68.
41. Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. European Respiratory Journal 2008; 31: 742-50.
42. Mannino D. Defining chronic obstructive pulmonary disease... and the elephant in the room. European Respiratory Journal 2007; 30: 189-90.
43. Lamprecht B, McBurnie MA, Vollmer W, et al. COPD in never smokers: Results from the population-based burden of obstructive lung disease study. Chest 2011; 139(4): 752-63.
44. Peters SP, Jones CA, Haselkorn T, et al. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. Journal of Allergy and Clinical Immunology 2007; 119(6): 1454-61.
45. Colice GL, Ostrom NK, Geller DE, et al. The CHOICE survey: high rates of persistent and uncontrolled asthma in the United States. Annals of Allergy, Asthma and Immunology 2012; 108(3): 157-62.
46. Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. Journal of Allergy and Clinical Immunology 2007; 120(6): 1360-7.
- Date modified: